NKX2-1 and lung carcinoma: In addition, of the genes involved in other cancers, 2/8 are related to gemcitabine: TGIF-1 modifies gemcitabine resistance in bladder cancer [39], and NKX2-1 higher expression increases gemcitabine cytotoxicity in lung cancer cells [40].